Utrecht
Netherlands
Amsterdam
Oncode Institute
Netherlands Cancer Institute - Division of Molecular Carcinogenesis
mCRPC, enzalutamide, epigenetics, androgen receptor, H3K27ac, HDAC inhibitors, biomarkers, hormone intervention